Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-06-17
1989-07-25
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514300, 514912, A61K 3144
Patent
active
048514152
ABSTRACT:
Certain quinolone and naphthyridine antibiotics are useful for treating ocular infections by topical administration.
REFERENCES:
patent: 4341784 (1982-07-01), Matsumoto et al.
patent: 4382937 (1983-05-01), Matsumoto et al.
patent: 4551456 (1985-11-01), Katz
patent: 4552882 (1985-11-01), Esteve-Soler
patent: 4649144 (1987-03-01), Matsumoto et al.
patent: 4665079 (1987-05-01), Culbertson et al.
patent: 4738968 (1988-04-01), Matsumoto et al.
General Ophthalmology-9th ed., pp. 42-43 (1985).
Heifetz Carl L.
Mich Thomas F.
Fay Zohreh
Robinson Douglas W.
Tinney Francis J.
Warner-Lambert & Company
LandOfFree
Ophthalmic use of naphthyridine antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic use of naphthyridine antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic use of naphthyridine antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358371